7th International Conference on

Stroke & Cerebrovascular Disease

February 26-27, 2025 | Prague | Czech Republic

Theme: Vision towards Stroke & Cerebrovascular Disease Recovery

About Conference
Past Conference Report
Sessions and Tracks
Market Analysis
About Conference

Scientific Meditech Conferences invites all the participants from all over the world to attend 7th International Conference on Stroke & Cerebrovascular Disease during February 26-27, 2025 | Prague | Czech Republic, with the Theme: Vision towards Stroke & Cerebrovascular Disease Recovery. Which includes keynote presentations, Oral talks, Poster presentations and Exhibitions.

 

This Stroke Conference 2025 goes to the heart of all matters relating to clinical trials, and it brings together the best scientists from around the world allowing you to hear and meet those at the forefront of our practice, and is being held in a fun location. There will be delegates not only from the UK or USA and other developed countries, but one feature is that delegates come from around the world

 

Stroke, Neurology Disorders & Neurovascular Diseases conference raises the following questions in Conference:

What do you think are the biggest public misconceptions of Stroke, Cerebrovascular Disease Neurology Disorders and  Neurovascular Diseases, Will science ever discover a cure for Stroke, Brain Injury, Neurotrauma and Neurovascular Diseases.

 

Speakers Benefits:

Access to All Sessions

Conference-Handbook & Kit

Certificate of Presentation by International Organizing Committee (IOCM)

Advertisement of Company logo at Conference website

Constant source of fresh ideas and insights from Peers

Accepted Abstracts will be labeled with DOI

Career Development and Interactive sessions

Visibility of your profile across world

Creation one web page for each participant.

 

Important Notes:

Conferene Date: February 26-27, 2025

Conference Location: Prague | Czech Republic

We are looking forward to welcoming you in-person for Stroke Conference 2025 in Prague!

Past Conference Report

6th International Conference on Stroke and Neurology Disorders was organized during September 04-05, 2023, Dubai, UAE , with the support and contribution of the Organizing Committee Members.

 

Firstly we must thank you for trusting us and participating at Stroke Conference, a global platform to discuss various important aspects of Neurology.

 

There are infinite reasons to extend our gratitude to you for making the  Stroke Conference 2023 outstanding Conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve  Stroke Conference 2023 a new heights in the field of Neuroscience.

 

The Conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries, who have driven this event into the path of success.

 

The Stroke Conference was organized around the theme “Stroke Awareness”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological disorders and Stroke with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

 

The Conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:

 

  • Jose Angel Larrea, Hospital Universitario Donostia, Spain
  • Adel ekladious, University of Western Australia, Australia
  • Alberto Maud, Texas Tech University Health Sciences Center, USA
  • Silvina Tonarelli, Texas Tech University Health Sciences Center, USA
  • Igor Goryanin, University of Edinburgh, UK
  • Oleg A. Shevelev, Federal Research and Clinical Centre for Resuscitation and Rehabilitology, Russia
  • Sumit Kumar Sonu, National Neuroscience Institute, Singapore
  • Mark S Kindy, University of South Florida, USA
  • Fazal-i-Akbar Danish, Yeovil District Hospital NHS Foundation Trust, UK
  • Ghaydaa A. Shehata, Assiut University, Egypt
  • Ansam Eghzawi, Jordan University of Science & Technology, Jordan
  • Mira Rakacolli-Kapisyzi, Chief of Neurovascular Service, University Hospital “Mother Theresa” Tirana, Albania
  • Mehrdad Farahani, Iran Stroke Organization, Iran
  • Mario Salmon Franz,, Hospital H+ Queretaro, Mexico
  • Jess Brain, The Brain Bar, USA
  • Zafar Hashim, Keele University, UK
  • Janet Sutherland Madden, Author, Advocates for Brain Health, USA
  • Juan Roly Condori Jamachi, Neurólogo-neurosonología vascular cerebral, Bolivia
  • Alexander Korotkikh, Regional Clinical Hospital №2 of Tyumen, Russia
  • Chika Okwuolisa, Brain and Spine Foundation, Africa
  • Vita Kusuma Rahmawti, RSUD Dr.Haryoto, Indonesia
  • Alberto Garcia De la Fuente, Christus Muguerza Hospital, Mexico
  • Aanchal Sareen, Uzhhorod National University, Ukraine
  • Rishabh Parihar, Uzhhorod National University, Ukraine
  • Alessandra Sanna, Azienda Ospedaliera Universitaria Sassar, Italy
  • Erica Edfort, Chamberlain University, USA

The Stroke Conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurological disorders and Stroke through their fabulous presentations at the podium of  Stroke Conference 2023

 

Scientific Meditech offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners, sponsors and Editorial Board Members of Journal of Neurology,  Journal of Brain Disorders & Therapy and  Journal of Brain Tumors & Neurooncology who supported the Webinar in every aspect for the awe-inspiring.

 

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members- Adam Wiśniewski, The Nicolaus Copernicus University in Toruń, Poland.

 

So as a continuation of  Stroke Conference 2023, we would like to heartily invite you to our upcoming 7th International Conference on Stroke & Cerebrovascular Disease scheduled during February 26-27, 2025 | Prague | Czech Republic

 

For Stroke Conference 2025 we are expanding our focus towards all aspects of Neurological Disorders and Stroke Re­search findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurological Disorders and Stroke.

 

Your expertise and knowledge in the area of Neurological Disorders and Stroke will provide an opportunity to discuss and respond to a series of questions about the status of advanced Neurological Disorders and Stroke therapeutics.

 

We would like to organize this Webinar with your support to gather all the Neurological Disorders and Stroke researchers in an single platform, hope we will be honoured with your support to organize  Stroke Conference 2025  in a grand level, your support will be the key of success for our next year conference.

 

We look forward to see your benign presence with active contribution and support to make this event successful once more.

 

Once again it’s our pleasure to welcome you to our upcoming:

 

7th International Conference on Stroke & Cerebrovascular Disease scheduled during February 26-27, 2025 | Prague | Czech Republic

Sessions and Tracks
  1. Intravenous Thrombolysis and Endovascular Clot Retrieval
  2. All Other Hyperacute and Acute Stroke Treatment Including Prehospital Care (Other than in 1)
  3. Intracerebral Hemorrhage
  4. Subarachnoid Hemorrhage, Aneurysms, Vascular Malformations
  5. Large Artery Atherosclerosis
  6. Small Vessel Disease
  7. Non-atheromatous Vasculopathies (incl. Moya-moya, Vasculitis)
  8. Carotid Revascularization
  9. Stroke Neuroimaging
  10. Stroke Biomarkers and Omics Research
  11. Population Health
  12. Basic Science and Translational Research
  13. Heart and Brain Studies
  14. COVID and Stroke
  15. Advances in Stroke Rehabilitation and Recovery
  16. Stroke Nursing
  17. Clinical Trials (Observational and Randomized Studies)
  18. Outcomes-Based Research
  19. Learning Healthcare
  20. Palliative and End of Life Care
  21. Stroke Prevention (Primary and Secondary)
  22. Neonatal and Pediatric Stroke
  23. Community Awareness and Advocacy
  24. Stroke Support Activities
  25. Health Services Research and Stroke Systems of Care
  26. Stroke in Low- and Middle-Income Countries
  27. Post Stroke Complications (incl. Depression, Sleep Disorders, Pain, Epilepsy)
  28. Systematic Reviews and Meta-Analyses
  29. Technological Innovations and Emerging Stroke Therapies
  30. Transient Ischemic Attacks
  31. Uncommon Stroke Disorders and Challenging Cases
  32. Vascular Cognitive Impairment and Dementia
  33. Data Sciences and Artificial Intelligence
  34. Stroke and Social Media – Information, Advocacy, and Empowerment
  35. Health Disparities, Social Determinants of Health and Health Economics
  36. Life after Stroke (incl. Caregiving)
  37. Stroke Pathways and Networks
  38. Novel Preventive Strategies and Post-stroke Care Concepts
  39. Stroke Risk Factors
  40. Atherosclerosis and Vascular Ageing
  41. Stroke in Systemic Disease
  42. Other Topics
Market Analysis

Stroke Conference 2025 primarily focuses for a destination to entrap research centers, associations, and organizations which are more prominently engaged in neurological disorders and stroke. This event will compile world level Neurologists, Psychiatrists, Neurosurgeons, clinical physicians, researchers, Directors, Professors, and Students from academia. It will also bring Government officials and global leaders together to establish innovative ideas in the Neurology department. Presently, Germany, the U.K., France, Switzerland, Italy, and Spain are the leading countries in the neurological disorder drugs market. The market study indicates that Switzerland will offer several growth opportunities in the overall medical market as awareness of these life-altering diseases grows.

 

EU Joint Programmed on Neurodegenerative Disease Research (JPND) gather 30 countries to increase the research and development by changing the research modalities, programmes and approaches. This has resulted in the creation of the largest global collaboration in the neuroscience field and represents an innovative approach to finding causes, developing treatment and finding appropriate techniques and methods to care for the people with neurodegenerative disease.

 

Importance and Scope:

The vital goal of  Stroke Conference  2025 is to build up an efficient platform for the scientists, neurologists, research scholars, major investigators, and industry experts to exchange their practical experiences in the field of Neuroscience and stroke. This forum will impart meeting and collaboration of the experts in neurology, physicians, researchers, and academics to endeavour new diagnosing techniques, management and prevention of stroke patients.

 

The major goal of this conference is to explore and inculcate new idea and techniques for neurological diseases and stroke. Stroke 2023 will conduct symposia, workshops, and other significant events in the diagnosis and management of the stroke and neurological disorders.

 

World Health Organization (WHO) has manifested the cerebrovascular diseases as a stroke, headache or a migraine which is the most common cause in most patients. Across the globe, around 82% of the patients with cerebrovascular diseases are manifesting these symptoms.

 

The market for neurological disease treatment is a diversified and most competitive sector possess a huge number of competitors. The major competitors are Teva Pharmaceutical Industries Ltd., GmbH, GlaxoSmithKline plc., Boehringer Ingelheim, Astra Zeneca, Merck & Co., Bayer AG, and F-Hoffmann-La Roche Ltd., concerning others.

 

Death Rate in Europe due to Stroke:

The data from the World Health Organization (WHO) is used to examine mortality trends in three particular types in Europe for 39 years of cerebrovascular disease between 1982 and 2019: ischaemic stroke, haemorrhagic stroke and sub-arachnoid haemorrhage (SAH), in which bleeding occurs between the brain and the surrounding membrane.

 

The investigators at the University of Bath, UK, found that across the whole of the WHO European region for the most recent period for which data were existing, there had been major decrease in death rates from all three types of cerebrovascular disease 68% of countries for men and women.

 

Major Associations around the Globe:

British Neuroscience Association

American Neuropsychiatric Association

Federation of European Neuroscience Societies

British Society for Neuroendocrinology

International Behavioral and Neural Genetics Society

Netherlands Institute for Neuroscience

International Behavioral Neuroscience Society

International Society for Neurochemistry

International Brain Bee

Japan Society of Neuro-vegetative Research

International Brain Research Organization

International Society for Autonomic Neuroscience

Society for Neuroscience

Society for Behavioral Neuroendocrinology

Society for Social Neuroscience

Nu Rho Psi

UCL Neuroscience

Luria Neuroscience Institute

Brain injury association of America

Neuropathy Association

The brain & behaviour research foundation

Alzheimer's Association

 

Universities associated with Neurological disorders and Stroke research in World

Stanford University

University of California

University of South Carolina Beauport

University of Helsinki

California Institute of Technology

Yale University

Harvard University

University of Pennsylvania

University of Chicago

The Kavli Institute for Brain Science

Cornell University

Johns Hopkins University

North-western University

Hacettepe University, Institute of Oncology, Turkey

Speaker Opportunities : Oral Presentation, Poster Presentation, E-Poster

 

Renowned Speakers


Hua Su,
University of California San Francisco, USA
Adel Ekladious
University of Western Australia, Australia
Pavel Novak
Storz Medical AG, Switzerland
Alberto Maud,
Associate Professor, Texas Tech University Health Sciences Center, USA
Dr Silvina Tonarelli
Program Director of the Psychiatry Residency Program at Texas Tech School of Medicine , USA
Jinshun Zhang,
Taizhou Hospital, Linhai, Zhejiang, China
Wei Li,
First Affiliated Hospital, Hainan Medical University, Haikou, Hainan, China.
Kıvılcım Kılıç
Boston University, USA
Janet Sutherland Madden
Advocate BAF, USA
Adam Wiśniewski,
The Nicolaus Copernicus University in Toruń, Poland
Stanlies D’Souza,
University of Massachusetts Medical School (UMMS), USA
Asem Ali,
Northern Lincolnshire and Goole NHS Foundation Trust, UK
Zachary T Bloomgarden
Icahn School of Medicine at Mount Sinai, USA
Rashmi Kumari
Pennsylvania State University, USA
Majaz Moonis
Director Stroke Services, Director Vascular Neurology Program, UMass Memorial Healthcare, USA
David Altschul
Montefiore Medical Center, USA
Leena Gupta,
Regional Medical Center, USA
Jacob Genizi
Bnai Zion Medical Center, Israel
Aanchal Sareen,
Uzhhorod National University, Ukraine

KEY TOPICS

  • Alzheimers Clinical Trials And Studies
  • Alzheimers Disease
  • Amnesia
  • Animal Models In Dementia
  • Anxiety
  • Autoimmune Disorders & Multiple Sclerosis
  • Behavioral Issues
  • Biopsychiatry
  • Blood-Brain Barrier
  • Brain Diagnosis
  • Brain Disease & Failure
  • Brain Injury
  • Brain Tumour
  • Central Nervous System
  • Cerebrovascular Disease
  • Child Neurology
  • Neural Engineering
  • Neural Enhancement
  • Neuro-Oncology
  • Neuroanaatomy
  • Neuroanatomy
  • Neurocritical Care
  • Neurotransmission
  • Neurotransmitters
  • Parkinson
  • Parkinsons Disease
  • CNS Tumors
  • Cognitive Disorders
  • Dementia
  • Dementia Care
  • Demyelination
  • Diagnosis And Therapy
  • Epilepsy
  • Genetics
  • Genetics And Epigenetics
  • Geriatric Neurology
  • Gut- Brain Axis
  • Headache
  • Intervention Neuroradiology
  • Meningitis
  • Mental Health
  • Mental Health Nursing
  • Metastatis
  • Movement Disorders
  • Multiple Sclerosis
  • Multiple Sclerosis Diagnosis
  • Nervous System
  • Neurodegeneration
  • Pediatric Neurology
  • Pharmacology
  • Psychiatry
  • Psychology
  • Neurodegenerative Disorder
  • Neurodegenerative Disorders
  • Neurogenetics
  • Neuroimaging
  • Neuroimmunology
  • Neurological Disorders
  • Neurological Disorders And Stroke
  • Neurological Infections
  • Neurological Surgery
  • Neurologist
  • Neurology
  • Neuromedicines
  • Neuromuscular Medicine
  • Neuronal Autoantibodies
  • Neuropathy
  • Neuropeptides
  • Neuropharmacology
  • Neuroscience
  • Neurosurgery
  • Neurotoxicology
  • Neurotoxins
  • Neurotransmission
  • Rehabilitation Therapy
  • Stem Cell Treatment For Neurological Disorders
  • Strokes
  • Traumatic Brain Injury
0
    0
    Your Cart
    Your cart is empty